By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



P.O. Box 12878

Research Triangle Park  North Carolina  27709  U.S.A.
Phone: 919-544-8600 Fax: 919-544-8697




Merck & Co.  Antifungals

Company News
SCYNEXIS, Inc. (SCYX) Announces Pricing Of Public Offering Of Common Stock 4/23/2015 7:46:04 AM
SCYNEXIS, Inc. (SCYX) Reports Full Year 2014 Financial Results 3/30/2015 1:21:46 PM
SCYNEXIS, Inc. (SCYX) To Present At Jefferies and Co. 2015 Antibiotic Summit 3/12/2015 7:52:15 AM
SCYNEXIS, Inc. (SCYX) To Present At RBC Capital Markets 2015 Healthcare Conference 2/19/2015 8:16:48 AM
SCYNEXIS, Inc. (SCYX) Names Marco Taglietti, M.D., Chief Executive Officer 2/6/2015 7:41:45 AM
SCYNEXIS, Inc. (SCYX) Receives FDA Fast Track Designation For Oral Formulation Of SCY-078 For The Treatment Of Patients With Invasive Fungal Infections 1/9/2015 7:42:58 AM
SCYNEXIS, Inc. (SCYX) Announces Appointment Of Two Seasoned Industry Professionals To Its Board Of Directors 12/4/2014 4:34:13 PM
SCYNEXIS, Inc. (SCYX) Reports Third Quarter 2014 Financial Results 11/13/2014 10:29:25 AM
SCYNEXIS, Inc. (SCYX) Enters Into Worldwide Agreement With Waterstone Pharmaceutical For The Development And Commercialization Of SCY-635 For Viral Diseases 11/3/2014 10:05:16 AM
SCYNEXIS, Inc. (SCYX) Reports Second Quarter 2014 Financial Results 8/13/2014 7:32:54 AM